$19.23-0.08 (-0.41%)
Sabra Health Care REIT, Inc.
Sabra Health Care REIT, Inc. in the Real Estate sector is trading at $19.23 with a market capitalization of $5.2B. Wall Street consensus targets $22.50 (14 analysts), implying a +17.0% move over the next 12 months. The stock is currently 16% below its 52-week high of $22.77, remaining 1.6% below its 200-day moving average. On fundamentals, Piotroski 5/9 shows mixed financial quality, Altman Z in the distress zone. The Whystock Score of 70/100 reflects bullish alignment across trend, valuation and analyst targets.
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $235.87Mβ | $221.75Mβ | $211.90Mβ | $190.04Mβ | $189.15M |
| Gross Profit | $143.59Mβ | $136.11Mβ | $131.49Mβ | $120.38Mβ | $128.05M |
| Operating Income | -$32.05Mβ | $68.33Mβ | $64.58Mβ | $59.55Mβ | $71.95M |
| Net Income | -$25.20Mβ | $40.88Mβ | $27.23Mβ | $22.54Mβ | $65.54M |
Sabra Health Care REIT, Inc. operates as a self-administered, self-managed real estate investment trust that, through its subsidiaries, owns and invests in real estate serving the healthcare industry throughout the United States and Canada. Sabra Hea...